A factoid depicting the AALL1731 clinical trial disease-free survival results. The top half of the factoid says "In children with standard-risk B-cell ALL adding blinatumomab to chemotherapy substantially improved disease-free survival." The bottom half has a box with "88%" on the left and then an arrow pointing a box with "96%" on the right.